Literature DB >> 28894968

Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.

Shigeto Sato1, Yuanzhe Li2, Nobutaka Hattori3.   

Abstract

Genes encoding lysosomal proteins, such as ATP13A2 and GBA, are associated with familial Parkinson's disease (PD). Heterozygous mutations in GBA are strongly associated with familial PD. ATP13A2, which encodes a lysosomal P-type ATPase, has been identified as the causative gene for Kufor-Rakeb syndrome. While lysosomal dysfunction due to these mutations exhibited early onset Parkinsonism, each animal model demonstrated different pathological mechanisms. Clinicogenetic and animal model studies recently identified several lysosomal alterations that play a role in the pathogenesis of PD.

Entities:  

Keywords:  ATP13A2; GBA; Gaucher disease; Kufor-Rakeb syndrome; Lysosome; Parkinson’s disease; α-Synuclein

Mesh:

Substances:

Year:  2017        PMID: 28894968     DOI: 10.1007/s00702-017-1779-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  32 in total

1.  Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.

Authors:  M Anheim; A Elbaz; S Lesage; A Durr; C Condroyer; F Viallet; P Pollak; B Bonaïti; C Bonaïti-Pellié; A Brice
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

Review 2.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.

Authors:  S Pablo Sardi; Jennifer Clarke; Cathrine Kinnecom; Thomas J Tamsett; Lingyun Li; Lisa M Stanek; Marco A Passini; Gregory A Grabowski; Michael G Schlossmacher; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

4.  α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.

Authors:  Lauren R Kett; Barbara Stiller; Megan M Bernath; Inmaculada Tasset; Javier Blesa; Vernice Jackson-Lewis; Robin B Chan; Bowen Zhou; Gilbert Di Paolo; Serge Przedborski; Ana Maria Cuervo; William T Dauer
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

5.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

6.  Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

Authors:  Valerie Cullen; S Pablo Sardi; Juliana Ng; You-Hai Xu; Ying Sun; Julianna J Tomlinson; Piotr Kolodziej; Ilana Kahn; Paul Saftig; John Woulfe; Jean-Christophe Rochet; Marcie A Glicksman; Seng H Cheng; Gregory A Grabowski; Lamya S Shihabuddin; Michael G Schlossmacher
Journal:  Ann Neurol       Date:  2011-04-06       Impact factor: 10.422

7.  Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome.

Authors:  A S Najim al-Din; A Wriekat; A Mubaidin; M Dasouki; M Hiari
Journal:  Acta Neurol Scand       Date:  1994-05       Impact factor: 3.209

Review 8.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

9.  Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.

Authors:  Valerie Cullen; Maria Lindfors; Juliana Ng; Anders Paetau; Erika Swinton; Piotr Kolodziej; Heather Boston; Paul Saftig; John Woulfe; Mel B Feany; Liisa Myllykangas; Michael G Schlossmacher; Jaana Tyynelä
Journal:  Mol Brain       Date:  2009-02-09       Impact factor: 4.041

10.  Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.

Authors:  Liyan Qiao; Shusei Hamamichi; Kim A Caldwell; Guy A Caldwell; Talene A Yacoubian; Scott Wilson; Zuo-Lei Xie; Lisa D Speake; Rachael Parks; Donna Crabtree; Qiuli Liang; Stephen Crimmins; Lonnie Schneider; Yasuo Uchiyama; Takeshi Iwatsubo; Yi Zhou; Lisheng Peng; YouMing Lu; David G Standaert; Ken C Walls; John J Shacka; Kevin A Roth; Jianhua Zhang
Journal:  Mol Brain       Date:  2008-11-21       Impact factor: 4.041

View more
  4 in total

Review 1.  Mitochondrial Dysfunction in Parkinson's Disease-Cause or Consequence?

Authors:  Chun Chen; Doug M Turnbull; Amy K Reeve
Journal:  Biology (Basel)       Date:  2019-05-11

2.  ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.

Authors:  Dan Wang; Hua Gao; Yanxia Li; Sen Jiang; Xinling Yang
Journal:  Biomed Res Int       Date:  2020-11-30       Impact factor: 3.411

3.  Genome-Scale Expression Pattern of Long Non-Coding RNAs in Chinese Uyghur Patients with Parkinson's Disease.

Authors:  Dan Wang; Hua Gao; Yanxia Li; Sen Jiang; Yuxuan Yong; Xinling Yang
Journal:  Med Sci Monit       Date:  2020-10-08

4.  ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology.

Authors:  Tao Dang; Wen-Jing Cao; Rong Zhao; Ming Lu; Gang Hu; Chen Qiao
Journal:  J Biomed Res       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.